To Evaluate the Effect of MCS® in Prostate Cancer Prevention

Clinical trial NCT02042807 · UNKNOWN

Trial details

NCT number: NCT02042807
Sponsor: Health Ever Bio-Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2014-10-01
Primary completion: 2024-12-01
Enrollment: 702

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.